Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Inhibition of influenza infection by glutathione.

Cai J, Chen Y, Seth S, Furukawa S, Compans RW, Jones DP.

Free Radic Biol Med. 2003 Apr 1;34(7):928-36.

PMID:
12654482
2.

Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy.

Sgarbanti R, Nencioni L, Amatore D, Coluccio P, Fraternale A, Sale P, Mammola CL, Carpino G, Gaudio E, Magnani M, Ciriolo MR, Garaci E, Palamara AT.

Antioxid Redox Signal. 2011 Aug 1;15(3):593-606. doi: 10.1089/ars.2010.3512. Epub 2011 May 19.

PMID:
21366409
3.

Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection.

Mebratu YA, Tipper J, Chand HS, Walton S, Harrod KS, Tesfaigzi Y.

Am J Respir Cell Mol Biol. 2016 May;54(5):664-73. doi: 10.1165/rcmb.2015-0133OC.

4.

Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.

Betts RJ, Mann TS, Henry PJ.

J Pharmacol Exp Ther. 2012 Dec;343(3):725-35. doi: 10.1124/jpet.112.196485. Epub 2012 Sep 17.

PMID:
22988062
5.

Construction of eukaryotic expression vector with mBD1-mBD3 fusion genes and exploring its activity against influenza A virus.

Li W, Feng Y, Kuang Y, Zeng W, Yang Y, Li H, Jiang Z, Li M.

Viruses. 2014 Mar 13;6(3):1237-52. doi: 10.3390/v6031237.

6.

Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice.

Kash JC, Xiao Y, Davis AS, Walters KA, Chertow DS, Easterbrook JD, Dunfee RL, Sandouk A, Jagger BW, Schwartzman LM, Kuestner RE, Wehr NB, Huffman K, Rosenthal RA, Ozinsky A, Levine RL, Doctrow SR, Taubenberger JK.

Free Radic Biol Med. 2014 Feb;67:235-47. doi: 10.1016/j.freeradbiomed.2013.10.014. Epub 2013 Oct 17.

7.

Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea.

Ling JX, Wei F, Li N, Li JL, Chen LJ, Liu YY, Luo F, Xiong HR, Hou W, Yang ZQ.

Acta Pharmacol Sin. 2012 Dec;33(12):1533-41. doi: 10.1038/aps.2012.80. Epub 2012 Sep 3.

8.

Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice.

Zhu Q, Chang H, Chen Y, Fang F, Xue C, Zhang F, Qiu M, Wang H, Wang B, Chen Z.

Biochem Biophys Res Commun. 2005 Apr 1;329(1):87-94.

PMID:
15721277
9.

Protective essential oil attenuates influenza virus infection: an in vitro study in MDCK cells.

Wu S, Patel KB, Booth LJ, Metcalf JP, Lin HK, Wu W.

BMC Complement Altern Med. 2010 Nov 15;10:69. doi: 10.1186/1472-6882-10-69.

10.

Combined efficacy of oseltamivir, isoprinosine and ellagic acid in influenza A(H3N2)-infected mice.

Pavlova EL, Simeonova LS, Gegova GA.

Biomed Pharmacother. 2018 Feb;98:29-35. doi: 10.1016/j.biopha.2017.12.014. Epub 2017 Dec 11.

PMID:
29241072
11.

Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation.

Kadowaki S, Chen Z, Asanuma H, Aizawa C, Kurata T, Tamura S.

Vaccine. 2000 Jun 15;18(25):2779-88.

PMID:
10812219
12.

Cell-Penetrating Mx1 Enhances Anti-Viral Resistance against Mucosal Influenza Viral Infection.

Jung HE, Oh JE, Lee HK.

Viruses. 2019 Jan 28;11(2). pii: E109. doi: 10.3390/v11020109.

13.
14.

Impairment of conjunctival glutathione secretion and ion transport by oxidative stress in an adenovirus type 5 ocular infection model of pigmented rabbits.

Kannan R, Gukasyan HJ, Zhang W, Trousdale MD, Kim KJ, Lee VH.

Free Radic Biol Med. 2004 Jul 15;37(2):229-38.

PMID:
15203194
15.

Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice.

Li H, Bradley KC, Long JS, Frise R, Ashcroft JW, Hartgroves LC, Shelton H, Makris S, Johansson C, Cao B, Barclay WS.

PLoS Pathog. 2018 Jan 4;14(1):e1006821. doi: 10.1371/journal.ppat.1006821. eCollection 2018 Jan.

16.

Cryptoporus volvatus extract inhibits influenza virus replication in vitro and in vivo.

Gao L, Sun Y, Si J, Liu J, Sun G, Sun X, Cao L.

PLoS One. 2014 Dec 1;9(12):e113604. doi: 10.1371/journal.pone.0113604. eCollection 2014.

17.

Glutathione attenuates ethanol-induced alveolar macrophage oxidative stress and dysfunction by downregulating NADPH oxidases.

Yeligar SM, Harris FL, Hart CM, Brown LA.

Am J Physiol Lung Cell Mol Physiol. 2014 Mar 1;306(5):L429-41. doi: 10.1152/ajplung.00159.2013. Epub 2014 Jan 17.

18.

Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses.

Mohan T, Kim J, Berman Z, Wang S, Compans RW, Wang BZ.

J Control Release. 2016 Jul 10;233:208-19. doi: 10.1016/j.jconrel.2016.05.021. Epub 2016 May 10.

19.

Intranasal co-administration of 1,8-cineole with influenza vaccine provide cross-protection against influenza virus infection.

Li Y, Xu YL, Lai YN, Liao SH, Liu N, Xu PP.

Phytomedicine. 2017 Oct 15;34:127-135. doi: 10.1016/j.phymed.2017.08.014. Epub 2017 Aug 18.

PMID:
28899494
20.

Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines.

Jang YH, Jung EJ, Byun YH, Lee KH, Lee EY, Lee YJ, Seong BL.

Vaccine. 2013 Jul 18;31(33):3339-46. doi: 10.1016/j.vaccine.2013.05.080. Epub 2013 Jun 3.

PMID:
23742997

Supplemental Content

Support Center